Dr. Juan Alderuccio, hematologist and lymphoma specialist, presented a phase 2 clinical trial at the 66th ASH Annual Meeting & Exposition Meeting.
The study evaluated the combination of medicine in 39 patients with relapsed or difficult-to-treat follicular #lymphoma. After great results with Sylvester patients, this study is expanding. 🙌 Discover how this innovative treatment is helping patients live longer, healthier lives. Learn more: Sylvester.org/ASH24. #ASH24
